SAU · 4015.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:19 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Jamjoom Pharmaceuticals Factory Company’s quoted price sits in the lower half of its reported 52-week range, 26.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jamjoom Pharmaceuticals Factory Company’s forward annual dividend is SAR 4.40 per share, paid semi-annual. The forward yield is 3.67% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jamjoom Pharmaceuticals Factory Company’s next earnings report is currently expected on Mar 2, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jamjoom Pharmaceuticals Factory Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1994, Jamjoom Pharmaceuticals Factory Company, headquartered in Jeddah, Saudi Arabia, is a key player in the production and commercialization of medicinal products. The firm serves markets both within the Kingdom of Saudi Arabia and across various international regions. Its extensive product portfolio addresses a wide array of therapeutic needs, covering ophthalmology, dermatology, gastrointestinal issues, cardiovascular health, central nervous system disorders, as well as general medicine, over-the-counter remedies, and nutraceuticals/consumer health products.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Jul 24, 2025 |
| SAR 1.890.0% vs estimate |
| SAR 396.22M+0.88% vs estimate |
| Q1 2025 | Apr 30, 2025 | SAR 2.24 | SAR 457.53M+0.26% vs estimate |
|---|
| Q4 2024 | Feb 25, 2025 | SAR 0.74 | SAR 259.70M-0.24% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 91.20+SAR 0.20 (+0.22%)
Nahdi Medical Company’s quoted price sits in the lower half of its reported 52-week range, 21.92% below the high.
SAR 55.20-SAR 0.40 (-0.72%)
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 103.00+SAR 0.10 (+0.1%)
Almoosa Health Company’s quoted price sits in the lower half of its reported 52-week range, 48.96% below the high.
SAR 27.42-SAR 0.18 (-0.65%)
Saudi Pharmaceutical Industries and Medical Appliances Corporation’s quoted price sits in the lower half of its reported 52-week range, 17.71% below the high.
SAR 61.20+SAR 0.25 (+0.41%)
Middle East Pharmaceutical Industries Company’s quoted price sits in the lower half of its reported 52-week range, 22.0% below the high.
